Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients
Conditions: Transplant Complication; CMV Interventions: Drug: Maribavir; Drug: Valganciclovir Sponsors: Medical University of South Carolina; Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
PREPARE- Prehabilitation for Patients Awaiting Liver Transplantation: Feasibility and Acceptability Testing.
Condition: Liver Transplant Intervention: Behavioral: Prehabilitation Sponsors: Belfast Health and Social Care Trust; Queen's University, Belfast Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Tocilizumab in Lung Transplantation
Condition: Lung Transplant Interventions: Drug: Tocilizumab; Drug: Placebo for Tocilizumab Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
PREPARE- Prehabilitation for Patients Awaiting Liver Transplantation: Feasibility and Acceptability Testing.
Condition: Liver Transplant Intervention: Behavioral: Prehabilitation Sponsors: Belfast Health and Social Care Trust; Queen's University, Belfast Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients
Conditions: Transplant Complication; CMV Interventions: Drug: Maribavir; Drug: Valganciclovir Sponsors: Medical University of South Carolina; Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Tocilizumab in Lung Transplantation
Condition: Lung Transplant Interventions: Drug: Tocilizumab; Drug: Placebo for Tocilizumab Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
PREPARE- Prehabilitation for Patients Awaiting Liver Transplantation: Feasibility and Acceptability Testing.
Condition: Liver Transplant Intervention: Behavioral: Prehabilitation Sponsors: Belfast Health and Social Care Trust; Queen's University, Belfast Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients
Conditions: Transplant Complication; CMV Interventions: Drug: Maribavir; Drug: Valganciclovir Sponsors: Medical University of South Carolina; Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
PREPARE- Prehabilitation for Patients Awaiting Liver Transplantation: Feasibility and Acceptability Testing.
Condition: Liver Transplant Intervention: Behavioral: Prehabilitation Sponsors: Belfast Health and Social Care Trust; Queen's University, Belfast Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients
Conditions: Transplant Complication; CMV Interventions: Drug: Maribavir; Drug: Valganciclovir Sponsors: Medical University of South Carolina; Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Tocilizumab in Lung Transplantation
Condition: Lung Transplant Interventions: Drug: Tocilizumab; Drug: Placebo for Tocilizumab Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2023 Category: Research Source Type: clinical trials
Lung Transplant READY CF 2: CARING CF Ancillary RCT
Condition: Cystic Fibrosis Intervention: Behavioral: Investigator-designed lung transplant education website Sponsors: University of Washington; Cystic Fibrosis Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2023 Category: Research Source Type: clinical trials
The Comparison Between Ringer Lactate Solution and Normal Saline in Post-Operative Period of Kidney Transplantation
Conditions: Electrolyte Imbalance; Kidney Transplant; Complications Interventions: Drug: Ringer's Lactate Crystalloid Solutions; Drug: Normal saline Sponsor: King Chulalongkorn Memorial Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2023 Category: Research Source Type: clinical trials
